glp 1 and nausea Cumulative incidence of nausea/vomiting caused by glucagon‐like Managing Side Effects of GLP-1

Diabetes 67(9):17101719 Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, VADT Investigators et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes

Get started Get $50 off your first month with code WELCOME Saxenda FAQs Saxenda is a medication that contains liraglutide, which belongs to a class of drugs known as GLP-1 receptor agonists

Digestive/GI side effects are common: nausea, vomiting, diarrhea, constipation, delayed gastric emptying (gastroparesis) have all been documented

DPP-4 inhibitors can be administered in patients with impaired kidney function due to the good safety and tolerability

Blood glucose levels in diabetic patients usually begin to stabilise during this period

In summary, while GLP-1s role in gastric motility offers potential therapeutic benefits, particularly in diabetes management, its implications for anesthesia and drug absorption necessitate careful consideration and highlight the need for ongoing research